Business Standard

Glenmark Life Sciences slips below issue price as stock falls 5%

On Friday, August 6, 2021, the company had made a quiet debut on the bourses as the shares listed at Rs 751.10 on the BSE

stocks, markets, funds, growth, investments
Premium

SI Reporter Mumbai
Shares of Glenmark Life Sciences (GLS) slipped below its issue price of Rs 720 per share on the BSE in intra-day trade on Monday as the stock declined 5 per cent to Rs 713.85. With today’s decline, the stock of the pharmaceutical company has slipped 11 per cent from its listing day high of Rs 799.95.

On Friday, August 6, 2021, GLS had made a quiet debut on the bourses as the shares listed at Rs 751.10, a 4 per cent premium against issue price on the BSE.

GLS, a developer and manufacturer of active pharmaceutical ingredients (APIs), is a wholly-owned subsidiary

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in